Cargando…
Management of Primary Central Nervous System Lymphoma Using Intra-Arterial Chemotherapy With Osmotic Blood-Brain Barrier Disruption: Retrospective Analysis of the Sherbrooke Cohort
BACKGROUND: Primary central nervous system lymphomas (PCNSL) are rare and aggressive CNS tumors. Current management involves high-dose methotrexate (HD-MTX) typically administered intravenously (IV), despite the existence of the blood-brain barrier (BBB), which significantly decreases its bioavailab...
Autores principales: | Iorio-Morin, Christian, Gahide, Gérald, Morin, Christophe, Vanderweyen, Davy, Roy, Marie-André, St-Pierre, Isabelle, Massicotte-Tisluck, Karine, Fortin, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7855856/ https://www.ncbi.nlm.nih.gov/pubmed/33552946 http://dx.doi.org/10.3389/fonc.2020.543648 |
Ejemplares similares
-
Drug Delivery Technology to the CNS in the Treatment of Brain Tumors: The Sherbrooke Experience
por: Fortin, David
Publicado: (2019) -
Struggling for breath in Sherbrooke - 1st Symposium on “One mitochondrion, many diseases” in Sherbrooke, Québec, Canada, March 11th, 2015
por: Braun, Ralf J., et al.
Publicado: (2015) -
Case-finding for disabilities with PRISMA-7 in emergency rooms: evolution in Sherbrooke, Québec
por: Raîche, Michel, et al.
Publicado: (2009) -
ODP038 Efficacy of Medical Treatment Compared to Unilateral Adrenalectomy in a Cohort of Patients with Primary Aldosteronism Treated at the Centre Hospitalier Universitaire de Sherbrooke – CHUS
por: Boily, Pascale, et al.
Publicado: (2022) -
Outbreak of severe Clostridium difficile-associated colitis with MOF in Quebec intensive care units: first analysis in Sherbrooke ICUs
por: Lamontagne, F, et al.
Publicado: (2005)